Influence of Aldo-keto Reductase 1C3 in Prostate Cancer - A Mini Review-Reference-Cited by-同舟云学术

Influence of Aldo-keto Reductase 1C3 in Prostate Cancer - A Mini Review

Published:2017-08-09 Issue:7 Volume:17 Page:
ISSN:1568-0096
Container-title:Current Cancer Drug Targets
language:en
Short-container-title:CCDT

Author:

Karunasinghe Nishi¹,Masters Jonathan²,Flanagan Jack U.³,Ferguson Lynnette R.³

Affiliation:

1. Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand

2. Urology Department, Auckland Hospital, Auckland, New Zealand

3. Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences (FM&HS), The University of Auckland, Auckland, New Zealand

Publisher

Bentham Science Publishers Ltd.

Subject

Cancer Research,Drug Discovery,Pharmacology,Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational modeling studies reveal the origin of the binding preference of 3‐(3,4‐di hydroisoquinolin‐2( 1H )‐ylsulfonyl)benzoic acids for AKR1C3 over its isoforms;Protein Science;2022-11-22

2. Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions;Scientific Reports;2022-01-07

3. In silico prediction of deleterious single nucleotide polymorphism in human AKR1C3 gene and identification of potent inhibitors using molecular docking approach;Journal of King Saud University - Science;2021-09

4. Spectroscopic investigations, concentration dependent SERS, and molecular docking studies of a benzoic acid derivative;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2021-03

5. Furazans in Medicinal Chemistry;Journal of Medicinal Chemistry;2021-02-11